SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-026649
Filing Date
2024-07-09
Accepted
2024-07-09 16:35:42
Documents
1
Period of Report
2024-07-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3246
  Complete submission text file 0001493152-24-026649.txt   5004
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ABEONA THERAPEUTICS INC. 1330 AVENUE OF THE AMERICAS - FLOOR 33 NEW YORK NY 10019
Business Address
Wuchterl Donald A. (Reporting) CIK: 0001857854 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 241107826